Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
private placement
MedTech
Mainz Biomed looks to shed ColoAlert
Mainz Biomed inked a private deal for $6 million and is looking to shed its colorectal cancer assets as it shifts its focus to pancreatic cancer.
Joseph Keenan
Feb 20, 2026 7:50am
Fierce Pharma
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
Aug 21, 2025 10:52am
Oruka spins out of Paragon with assets, public listing and cash
Apr 3, 2024 7:30am
Avrobio's corporate tremor attracts Tectonic for reverse merger
Jan 30, 2024 3:24pm
BridgeBio bags $250M in stock sale before acoramidis submission
Sep 25, 2023 11:20am
SpringWorks enjoys double payday from GSK deal, $225M funding
Sep 7, 2022 10:49am
